Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Page 1
Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
Gupta P, Patterson BC, Chu L, Gold S, Amos S, Yeung H, Goodman M, Tangpricha V. Gupta P, et al. Among authors: tangpricha v. J Clin Endocrinol Metab. 2023 Oct 18;108(11):e1236-e1244. doi: 10.1210/clinem/dgad306. J Clin Endocrinol Metab. 2023. PMID: 37246711
RESULTS: Among 385 eligible participants, 231 (60%) were assigned male at birth and 154 (40%) were assigned female at birth. Less than one-third of participants (n = 121) initiated GAHT prior to their 18th birthday, constituting the pediatric cohort (mean age 15 yea …
RESULTS: Among 385 eligible participants, 231 (60%) were assigned male at birth and 154 (40%) were assigned female at birth. L …
Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L, Zhang Q, Getahun D, Jasuja GK, McCracken C, Pisegna J, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Hashemi L, et al. Among authors: tangpricha v. J Sex Med. 2021 Sep;18(9):1662-1675. doi: 10.1016/j.jsxm.2021.06.011. Epub 2021 Aug 5. J Sex Med. 2021. PMID: 34366264 Free PMC article.
The main limitations include the lack of information on hormone levels and the inability to take into account GAHT doses and routes of administration. CONCLUSION: The influence of long-term GAHT on ALT and AST levels appears modest and not likely to reflect clinically mean …
The main limitations include the lack of information on hormone levels and the inability to take into account GAHT doses and routes of admin …
Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
Suppakitjanusant P, Ji Y, Stevenson MO, Chantrapanichkul P, Sineath RC, Goodman M, Alvarez JA, Tangpricha V. Suppakitjanusant P, et al. Among authors: tangpricha v. J Clin Transl Endocrinol. 2020 Jul 3;21:100230. doi: 10.1016/j.jcte.2020.100230. eCollection 2020 Sep. J Clin Transl Endocrinol. 2020. PMID: 32685379 Free PMC article.
INTRODUCTION: Many transgender people take hormone therapy to affirm their gender identity. One potential long-term consequence of gender affirming hormone therapy is increased body mass index (BMI), which may be associated with metabolic syndrome, cardiovascular disease a …
INTRODUCTION: Many transgender people take hormone therapy to affirm their gender identity. One potential long-term consequence of ge …
Cystic fibrosis bone disease: Pathophysiology, assessment and prognostic implications.
Anabtawi A, Le T, Putman M, Tangpricha V, Bianchi ML. Anabtawi A, et al. Among authors: tangpricha v. J Cyst Fibros. 2019 Oct;18 Suppl 2:S48-S55. doi: 10.1016/j.jcf.2019.08.018. J Cyst Fibros. 2019. PMID: 31679729 Free article. Review.
Cystic fibrosis bone disease (CFBD) is a common long-term complication of cystic fibrosis (CF) that can lead to increased fractures and significant morbidity and mortality in this patient population. ...
Cystic fibrosis bone disease (CFBD) is a common long-term complication of cystic fibrosis (CF) that can lead to increased fractures a …
Endocrinology of Transgender Medicine.
T'Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V. T'Sjoen G, et al. Among authors: tangpricha v. Endocr Rev. 2019 Feb 1;40(1):97-117. doi: 10.1210/er.2018-00011. Endocr Rev. 2019. PMID: 30307546 Review.
Mental health problems such as depression and anxiety have been found to reduce considerably following hormonal treatment. Future studies should aim to explore the long-term outcome of hormonal treatment in transgender people and provide evidence as to the effect of gender …
Mental health problems such as depression and anxiety have been found to reduce considerably following hormonal treatment. Future studies sh …
Agreement between medical records and self-reports: Implications for transgender health research.
Gerth J, Becerra-Culqui T, Bradlyn A, Getahun D, Hunkeler EM, Lash TL, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Gerth J, et al. Among authors: tangpricha v. Rev Endocr Metab Disord. 2018 Sep;19(3):263-269. doi: 10.1007/s11154-018-9461-4. Rev Endocr Metab Disord. 2018. PMID: 30219985 Free PMC article. Review.
A key priority of transgender health research is the evaluation of long-term effects of gender affirmation treatment. Thus, accurate assessment of treatment receipt is critical. ...
A key priority of transgender health research is the evaluation of long-term effects of gender affirmation treatment. Thus, accurate …
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Safer J, Slovis J, Tangpricha V, Goodman M. Getahun D, et al. Among authors: tangpricha v. Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10. Ann Intern Med. 2018. PMID: 29987313 Free PMC article.
Ten male and 10 female cisgender enrollees were matched to each transgender participant by year of birth, race/ethnicity, study site, and index date enrollment. SETTING: Kaiser Permanente in Georgia and northern and southern California. ...CONCLUSION: The patterns of incre …
Ten male and 10 female cisgender enrollees were matched to each transgender participant by year of birth, race/ethnicity, study site, …
2017 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/ENDOCRINE SOCIETY UPDATE ON TRANSGENDER MEDICINE: CASE DISCUSSIONS.
Tangpricha V, Hannema SE, Irwig MS, Meyer WJ 3rd, Safer JD, Hembree WC. Tangpricha V, et al. Endocr Pract. 2017 Dec;23(12):1430-1436. doi: 10.4158/GL-2017-0115. Endocr Pract. 2017. PMID: 29320643
RESULTS: Six cases are presented that illustrate the diagnosis, treatment, and long-term management of trans-gender children and adults based on the revised guidelines for the endocrine care of gender-dysphoric and gender-nonconforming persons. ...Important aspects of care …
RESULTS: Six cases are presented that illustrate the diagnosis, treatment, and long-term management of trans-gender children and adul …
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
Ikeno F, Brooks MM, Nakagawa K, Kim MK, Kaneda H, Mitsutake Y, Vlachos HA, Schwartz L, Frye RL, Kelsey SF, Waseda K, Hlatky MA; BARI-2D Study Group. Ikeno F, et al. J Am Coll Cardiol. 2017 Jan 31;69(4):395-403. doi: 10.1016/j.jacc.2016.10.067. J Am Coll Cardiol. 2017. PMID: 28126156 Free article.
22 results